Seqirus – Banksia Project Banksia involves the design, construction, validation and registration of a new state-of-the-art biopharmaceutical facility, which will use innovative cell-based technology to produce influenza vaccines for use in both influenza pandemics and seasonal vaccination programs. This will be the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere. The facility will […]


MX3 and ADS Beam Lines ANSTO via the Australian Synchrotron is undertaking a program of beamline builds collectively known as the ‘BRIGHT Beamlines’. This program will see an expansion of capability and capacity to the facility which reflects the facilities importance in supporting scientific endeavour in the region. The synchrotron is a 3rd generation light […]